ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,329,000 | +84.1% | 100,694 | +34.2% | 0.01% | +66.7% |
Q2 2021 | $9,413,000 | -8.0% | 75,010 | -0.6% | 0.00% | 0.0% |
Q1 2021 | $10,234,000 | +3.6% | 75,467 | -2.3% | 0.00% | 0.0% |
Q4 2020 | $9,883,000 | +25.4% | 77,252 | +10.3% | 0.00% | 0.0% |
Q3 2020 | $7,883,000 | +91.0% | 70,056 | +61.7% | 0.00% | +50.0% |
Q2 2020 | $4,128,000 | +5404.0% | 43,335 | +5102.3% | 0.00% | – |
Q1 2020 | $75,000 | -50.3% | 833 | -70.7% | 0.00% | – |
Q4 2019 | $151,000 | +4933.3% | 2,847 | +3172.4% | 0.00% | – |
Q3 2019 | $3,000 | -62.5% | 87 | -55.6% | 0.00% | – |
Q2 2019 | $8,000 | +33.3% | 196 | +63.3% | 0.00% | – |
Q1 2019 | $6,000 | -14.3% | 120 | -23.6% | 0.00% | – |
Q4 2018 | $7,000 | -87.7% | 157 | -84.3% | 0.00% | – |
Q3 2018 | $57,000 | +338.5% | 997 | +282.0% | 0.00% | – |
Q2 2018 | $13,000 | +550.0% | 261 | +715.6% | 0.00% | – |
Q1 2018 | $2,000 | -85.7% | 32 | -89.9% | 0.00% | – |
Q4 2017 | $14,000 | -87.8% | 316 | -89.7% | 0.00% | – |
Q3 2017 | $115,000 | +3733.3% | 3,079 | +3359.6% | 0.00% | – |
Q2 2017 | $3,000 | -88.5% | 89 | -91.0% | 0.00% | – |
Q1 2017 | $26,000 | -36.6% | 988 | -38.7% | 0.00% | – |
Q4 2016 | $41,000 | +1266.7% | 1,611 | +2106.8% | 0.00% | – |
Q3 2016 | $3,000 | +50.0% | 73 | +40.4% | 0.00% | – |
Q2 2016 | $2,000 | +100.0% | 52 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 52 | +57.6% | 0.00% | – |
Q4 2015 | $2,000 | -92.3% | 33 | -96.8% | 0.00% | – |
Q3 2015 | $26,000 | -40.9% | 1,041 | -26.0% | 0.00% | – |
Q2 2015 | $44,000 | +780.0% | 1,406 | +1024.8% | 0.00% | – |
Q1 2015 | $5,000 | -37.5% | 125 | -35.6% | 0.00% | – |
Q4 2014 | $8,000 | – | 194 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |